Putting ‘Super’ in Natural Killer Cells

Putting ‘Super’ in Natural Killer Cells Deleting an inhibitory gene in natural killer cells derived from induced pluripotent stem cells is found to boost their anti-tumor activity and persistence; researchers now seek to develop a clinical therapy. Read more...

Promising New Treatment for Recurrent Pediatric Brain Cancer

Promising New Treatment for Recurrent Pediatric Brain Cancer Two pediatric brain cancers that are challenging to treat if they recur, medulloblastoma and ependymoma, are the target of a clinical trial using a new type of therapy. A multi-institutional, international team led by researchers at Baylor College of Medicine, Texas Children’s